ATLANTA (KVOA) - The Centers for Disease Control and Prevention (CDC) reports a significant rise in NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE), a drug-resistant bacteria, posing a serious public health threat.

Between 2019 and 2023, NDM-CRE infections in the U.S. surged by more than 460%, making them difficult to treat and potentially deadly. Limited testing capabilities in many labs further complicate detection.

“This sharp rise in NDM-CRE means we face a growing threat that limits our ability to treat some of the most serious bacterial infections,” said Danielle Rankin, an epidemiologist in CDC’s Division of Healthcare Quality Promotion.

NDM-CRE bacteria are resistant to strong antibiotics due to the enzyme "NDM," leaving few treatment options. The increase in infec

See Full Page